Category Archives: Cancer Research

Mikhail Blagosklonny and His Take about Oncology

Published / by Crossfit / Leave a Comment

As Professor of Oncology Mikhail Blagosklonny has his own take on the best approach to adopt. Currently working as a professor of oncology at the Roswell Park Cancer Institute, Blagosklonny is internationally renowned for his work on cancer and the aging phenomenon. He is an MD in medicine from the First Pavlov State Medical University of St. Petersberg. From the same University, he also earned a Ph.D. in experimental medicine and cardiology.

In the year 2002, he was made associate professor of medicine at New York Medical College, Valhalla. Post that he served was at Ordway Research Institute. It was in 2009 that he finally made it to Roswell Park as professor of oncology. His varied experience meant that he became an outstanding professor in his field of specialization. Read more on Healing Magic

Among his foremost research interests are biogerontology, anti-aging and cancer drugs and specific cancer therapies that protect healthy cells from harm. Apart from the above, he also works in the capacity of editor-in-chief of Oncotarget and Cell Cycle. Other than holding these positions he also happens to be the editor of Cancer Biology and Therapy. That’s not all. Blagosklonny is on the Cell Death and Differentiation editorial board.

Among his sterling contributions to medical science has been the propounding of the idea that supports the role of well known cancer drug rapamycin as a means of extending life. He has based this on extensive research that he has carried out on the subject that encompasses cellular and microbiology to clinical investigations. In the main, it comprises of signal transduction , ontogenesis, tumor suppressors and drug resistance of normal cells among other things.

Apart from all of the above Blagosklonny is an author of the aging hyperfunction theory. In addition to that, he is known to write about cell cyclotherapy and chemotherapeutic engineering. Blagosklonny above all is a keen believer that both cancer and aging can be checked. That is a major reason for him to advocate the use of rapamycin aggressively.

With more than 300 research articles, books chapters and reviews published under his name Mikhail Blagosklonny is definitely a highly respected authority in the field of medical sciences. Moreover, he has other feathers in his cap like associate editorship of PLOS ONE, the American Journal of Pathology and the International Journal of Cancer. If today Blagosklonny is one of the world’s foremost oncology researchers, it is because of the tremendous amount of hard work he has put into it. View his LinkedIn profile

This is possible only if one has the passion to not only excel in any field but for also serving others through it. Blagosklonny firmly believes that it is his vision and passion to see a disease free world that makes him work as hard as he does. It is always pioneers like him, whose fierce passion for something they believe in from the innermost recesses of their heart, who make discoveries that change the course of the world. Blagoklonny is surely one of those. The coming times will see him get vindicated even more emphatically than he already has been.

Eric Lefkofsky – Helping Make Tremendous Progress in Cancer Research Through Data Aggregation

Published / by Crossfit / Leave a Comment

Cancer has taken millions of lives over the years and continued to spread like an epidemic all over the world. Pharmaceutical and biotechnology companies are burning the midnight oil to find a cure to this terminal disease to save lives. Even though there has been a rapid advancement in the field of cancer therapies, there are many questions still unanswered, and many puzzles that remain unsolved. It is where the role of centralized and integrated data from cancer patients can play a significant role in helping the physicians and scientists to provide better cancer treatment.

Eric Lefkofsky, better known as the founder and Chairman of GrouponInc, a company that aggregates merchant deals to pass on the benefits to the consumers, is also the co-founder of Tempus. Tempus is dedicated to gathering cancer-related data in a segregated and organized manner that would make it usable for the physicians and the cancer-based scientists. Eric Lefkofsky believes that there is ample amount of patient data available, but no proper source where therapeutic and genomic information can be available at one place. He further explained in detail how there is an urgent need for such source of accurate patient data in San Diego at the Fortune Brainstorm Health Conference.

Mr Lefkofsky told what Tempus does and how it gathers and provides molecular, clinical, therapeutic, and outcome response data at one place. He says that such data would help in knowing why one medicine works for some patients while not working or mildly working with other cancer patients. Eric stated that such data should be readily available to the researchers so that they can pinpoint the problem with the therapies and know what is lacking so that they can fill the void.

Eric Lefkofsky is one of the most successful entrepreneurs in the United States, and apart from being the co-founder of GrouponInc and Tempus, he is also the founding partner at Lightbank, a venture capital firm and Uptake Technologies, one of the most sought after predictive analytics platform. He is also the founder of Mediaocean, a company that offers media procurement technology, and InnerWorkings, a leading company providing print, media, and promotional solutions.

Twitter: Twitter.com/lefkofsky

Eric Lefofsky on Tempus and What’s Close to His Heart

Published / by Crossfit / Leave a Comment

The idea behind Tempus is that the company works to help people who have cancer. On one side of the company, Lefofsky works to help families and the people who have the diagnoses deal with the disease. On the other side of the company is the professional geneticist who is working to come up with solutions for the disease. They are not only working together for a cure but are also working to help make the way of living with cancer much more tolerable for the people who have it. Mr Eric Lefofsky knows that this is important because he has been through the disease with his wife. He was personally touched by cancer and knew that it was his duty to make sure that people were going to be able to make sure that things would work better for everyone who had the disease. While dealing with cancer, Eric Lefofsky came up with the idea for Tempus.

Even though Eric had been very successful with his business and was actually able to retire early, that didn’t mean that he wasn’t touched personally by cancer. He knows that it is something that affects everyone and that he is able to get more out of life with the help of a support system. He worked in that way for his wife and that helped her to heal more comfortably. He wanted to make things easier for everyone who had the disease and decided that using the idea behind Tempus was the right way for him to do it. Click here to know more.

Eric Lefofsky was able to retire early initially because of the options that he had. He worked hard on Groupon and made it a very popular option for all people who wanted to save money. While it was successful when it first started out in the Chicago area, it grew exponentially and was eventually able to branch out into different areas. It is now an international company and Lefofsky is able to enjoy the money that has come into him as a result of it. He didn’t know that it would be as successful as what it is.

Eric Lefofsky on Facebook.

The Dedication And New Technology Of The Cancer Treatment Centers of America

Published / by Crossfit / Leave a Comment

The Cancer Treatment Centers of America have collaborated with Allscripts and NantHealth to implement a customized technical solution. This will give them access to the workflow contained in the Allscripts Sunrise electronic health records. This program gives information regarding the process of treating cancer without any interruption to the physician. Hundreds of oncologists nationwide have made contributions and the result is a collection of data regarding cancer.

The new system will show all of the treatment options available and prevent guesswork. A patients standard for care will be customized, efficient and safe. The oncologists will have access to the latest cancer research, complimentary therapies and treatment regimens. Supportive therapies and clinical approaches based on evidence will be used to optimize a patients cancer treatment. Also included are the current guidelines, adverse drug reactions, response rates and toxicity.

Since the system has an integrated platform the medical personnel can compare and discuss different treatment regimens and have more confidence in their diagnosis and treatment. The approval of insurance providers can be expedited with data providing the necessary information regarding treatment strategies. In addition the regimen of chemotherapy as well as the ordering process are improved. Information can also be retrieved from a medical library which covers the cost of treatments, clinical outcomes, toxicities and literature.

The Cancer Treatment Centers of America are based out of Boca Raton, Florida. They are a national network including five hospitals who provide care for patients with cancer. They use a combination of genomic testing, surgery, immunotherapy, precision cancer treatment, radiation and chemotherapy.

The Myctca.com/ use therapies that have been designed to enhance their patients quality of life. They offer emotional and physical support and manage any side effects both during the treatment process as well as after. Their hospitals in Chicago, Phoenix, Tulsa, Atlanta and Chicago offer help to patients worldwide.

The Cancer Treatment Centers of America have been consistently rated as hospitals who give an extremely high quality of care to their patients. They discuss treatment information with their patients and their families and encourage them to participate in the discussions and make active decisions.

For more information on Cancer Treatment Centers of America follow them on Facebook and Twitter.